Researchers from the Keck School of Medicine of USC have developed a new type of chimeric antigen receptor (CAR) T cell that elicits a more controlled immune response to cancer in mice—effectively ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback